Clinical Trial Update: Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial completed evaluating the toxicity of allogeneic stem cell transplantation in relapsed or therapy-refractory Ewing sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Snippet

Sponsor: University of Louisville | Conditions: EWINGS SARCOMA | Phase 1 | Status: COMPLETED